Current Influenza Antiviral Drug Strategy Limitations and Future Development of both Preventative and Intervention Antiviral Therapies

Authors: Ahmad F.¹
Affiliations:
1. Department of Infectious Disease, Scientific Platform Division, Southern Research
Issue: Vol 19, No 3 (2024)
Pages: 179-181
Section: Medicine
URL: https://vietnamjournal.ru/2772-4344/article/view/644545
DOI: https://doi.org/10.2174/0127724344248640231010042648
ID: 644545

Cite item

Full Text

Influenza virus, vaccine, efficacy, therapeutics, prevention, RdRp, IAV.

Department of Infectious Disease, Scientific Platform Division, Southern Research

Author for correspondence.
Email: info@benthamscience.net

Palese P, Shaw ML. Orthomyxoviridae: The viruses and their replication. In: Fields Virology. 5 th . Philadelphia: Lippincott-Raven Press 2007; pp. 1647-90.
Centers for Disease Control Prevention. 2011. Available from: http://www.cdc.gov/flu/about/disease/index.htm
Shiraishi K, Mitamura K, Sakai-Tagawa Y, Goto H, Sugaya N, Kawaoka Y. High frequency of resistant viruses harboring different mutations in amantadine-treated children with influenza. J Infect Dis 2003; 188(1): 57-61. doi: 10.1086/375799 PMID: 12825171
Garten RJ, Davis CT, Russell CA, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009; 325(5937): 197-201. doi: 10.1126/science.1176225 PMID: 19465683
Bright RA, Shay DK, Shu B, Cox NJ, Klimov AI. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA 2006; 295(8): 891-4. doi: 10.1001/jama.295.8.joc60020 PMID: 16456087
Fang Q, Wang D. Advanced researches on the inhibition of influenza virus by Favipiravir and Baloxavir. Biosaf Heal 2020; 2(2): 64-70. doi: 10.1016/j.bsheal.2020.04.004

Supplementary Files

Action

1. JATS XML